Skip to main content
All tenders

Discount Agreements for Pharmaceutical Active Ingredients

Status
Active
Submission Deadline
284 days remaining
Contracting authority
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/13 more open tenders view
Location
Eschborn, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-452324-2025

AOK Hessen is offering interested pharmaceutical companies the opportunity to join discount agreements for various active ingredients, aiming for uniform conditions and access procedures.

Free

Never miss a tender again

We send you 3 current matches that fit your company.

With a number we call briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email and, if you leave a number, calls you once about it. Revocable at any time. Privacy policy


Tender documents

  • Portal — LOT-0001NON-RESTRICTED-DOCUMENT
  • TED HTML — 452324-2025HTML
  • TED PDF — 452324-2025PDF
  • TED XML — 452324-2025XML
Free

Unlock documents for free

Enter your email address. If you confirm, we will also send you 3 similar tenders.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy


Lots (13)

  • LOT-0001Alitretinoin (ATC D11AH04)
  • LOT-0002Budesonid (ATC A07EA06)
  • LOT-0003Desloratadin (ATC R06AX27)
  • LOT-0004Erythropoetin (ATC B03XA01)
  • LOT-0005Ganirelix (ATC H01CC01)
  • LOT-0006Golimumab (ATC L04AB06)
  • LOT-0007Goserelin (ATC L02AE03)
  • LOT-0008Mepolizumab (ATC R03DX09)
  • LOT-0009Methoxy-polyethylenglycol-Epoetin beta (ATC B03XA03)
  • LOT-0010Natalizumab Injektion (ATC L04AG03)
  • LOT-0011Natalizumab ohne Injektion (ATC L04AG03)
  • LOT-0012Nilotinib (ATC L01EA03)
  • LOT-0013Octreotid (ATC H01CB02)

Additional details

EU Funded
Yes
Electronic Submission
Not allowed
Legal Basis
32014L0024
Live webinar

See Patterno work on a real tender

45 minutes live, questions answered in the chat. Upcoming dates on the signup page.

  • Matches from 4,500+ portals in one workspace
  • Qualify any tender against your criteria in minutes
  • Prepare bid documents from your company context

Prefer a private session?